HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masako Mitsumata Selected Research

fibroblast activation protein alpha

10/2006Activation of EDTA-resistant gelatinases in malignant human tumors.
9/2005'Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer'.
1/2004The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma.
9/2003Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer.
7/2003Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm.
1/2003Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masako Mitsumata Research Topics

Disease

10Atherosclerosis
10/2017 - 08/2003
8Atherosclerotic Plaque (Atheroma)
10/2017 - 08/2003
7Neoplasms (Cancer)
10/2006 - 01/2002
5Neoplasm Metastasis (Metastasis)
09/2005 - 01/2003
3Myocardial Infarction
06/2010 - 11/2006
3Carcinoma (Carcinomatosis)
10/2006 - 07/2003
3Lymphatic Metastasis
09/2005 - 01/2003
2Neointima
01/2022 - 11/2006
2Hemorrhage
11/2018 - 04/2016
2Rupture
11/2008 - 02/2006
2Aneurysm (Aneurysms)
11/2008 - 02/2006
2Infarction (Infarctions)
11/2006 - 01/2006
2Adenocarcinoma
10/2006 - 01/2003
2Melanoma (Melanoma, Malignant)
10/2006 - 01/2004
2Colorectal Neoplasms (Colorectal Cancer)
09/2005 - 09/2003
2Stomach Neoplasms (Stomach Cancer)
01/2004 - 01/2003
1Atrial Fibrillation
01/2022
1Dyslipidemias (Dyslipidemia)
01/2021
1Body Weight (Weight, Body)
12/2015
1Cicatrix (Scar)
06/2010
1Coronary Stenosis (Coronary Artery Stenosis)
08/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
08/2009
1Interstitial Lung Diseases (Interstitial Lung Disease)
03/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2009
1Intestinal Failure
01/2009
1Hypoxia (Hypoxemia)
11/2008
1Vascular Remodeling
11/2006
1Hyperplasia
11/2006
1Ventricular Remodeling
11/2006
1Ductal Carcinoma
10/2006
1Hyperglycemia
10/2006
1Type 2 Diabetes Mellitus (MODY)
10/2006
1Heart Arrest (Cardiac Arrest)
02/2006
1Vasculitis (Vasculitides)
02/2006
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2006
1Inflammation (Inflammations)
11/2004
1Breast Neoplasms (Breast Cancer)
01/2004
1Uterine Cervical Dysplasia
07/2003
1Signet Ring Cell Carcinoma
01/2003

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
07/2010 - 01/2003
6fibroblast activation protein alphaIBA
10/2006 - 01/2003
5GelatinasesIBA
10/2006 - 01/2003
5Serine Proteases (Serine Protease)IBA
09/2005 - 01/2003
4Messenger RNA (mRNA)IBA
07/2010 - 01/2004
3CholesterolIBA
12/2015 - 01/2002
2LipidsIBA
12/2015 - 03/2009
2PPAR gammaIBA
07/2010 - 01/2004
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2010 - 01/2004
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2010 - 11/2008
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2010 - 11/2006
2ApolipoproteinsIBA
03/2009 - 07/2007
2Glucose (Dextrose)FDA LinkGeneric
07/2007 - 10/2006
2CollagenIBA
10/2006 - 08/2003
2Peptide Hydrolases (Proteases)FDA Link
10/2006 - 01/2004
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022
1AnticoagulantsIBA
01/2022
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022
1Angiotensin IIIBA
01/2021
1ferric ferrocyanide (Prussian blue)FDA Link
11/2018
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2017
1Fluspirilene (Imap)IBA
10/2017
1Glucagon-Like Peptide-1 ReceptorIBA
10/2017
1lixisenatideIBA
10/2017
1LDL Receptors (LDL Receptor)IBA
04/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2016
1pitavastatin (itavastatin)FDA Link
02/2016
1ChemokinesIBA
09/2010
1PPAR alphaIBA
07/2010
1Collagen Type IV (Type IV Collagen)IBA
06/2010
1Lipoprotein(a)IBA
08/2009
1LDL CholesterolIBA
08/2009
1HDL CholesterolIBA
08/2009
1Phenobarbital (Luminal)FDA Link
03/2009
1oxidized low density lipoproteinIBA
03/2009
1UbiquitinIBA
03/2009
1Lipoproteins (Lipoprotein)IBA
03/2009
1EnzymesIBA
11/2008
1Leukocyte Elastase (Neutrophil Elastase)IBA
11/2008
1Peroxidase (Myeloperoxidase)IBA
11/2008
1ElastinIBA
01/2008
1Glycoside Hydrolase InhibitorsIBA
07/2007
1Blood Glucose (Blood Sugar)IBA
07/2007
1CytokinesIBA
11/2006
1LectinsIBA
10/2006
1Glycoproteins (Glycoprotein)IBA
10/2006
1Edetic Acid (EDTA)FDA Link
10/2006
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
10/2006
1Protein Isoforms (Isoforms)IBA
11/2004
1ProstaglandinsIBA
11/2004
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2004
1GelatinIBA
01/2004

Therapy/Procedure

3Therapeutics
06/2010 - 01/2009
2Transplantation
06/2010 - 11/2009
1Drug-Eluting Stents
01/2022
1Cell Transplantation
11/2009
1Ligation
11/2006
1Cardiopulmonary Resuscitation (CPR)
02/2006
1Critical Care (Surgical Intensive Care)
02/2006
1Catheters
01/2006
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2006